Skip to main content
Equibles

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1164508 BOSTON, MA
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$22,513,504
-$752,166 QoQ
Shares Held
621,920
-11.6% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 280 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. COLL ranks #10 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,137,442 $225,456,582
2 VTRS
Viatris Inc
 8,371,218 $132,934,941
3 HLN
Haleon plc
 14,181,817 $132,316,352
4 INDV
Indivior Pharmaceuticals, Inc.
 1,642,086 $67,374,788
5 KNSA
Kiniksa Pharmaceuticals International, plc
 957,514 $61,233,020
6 TAK
Takeda Pharmaceutical Co Ltd
 3,732,924 $59,838,771
7 ANIP
Ani Pharmaceuticals Inc
 562,016 $46,523,684
8 ELAN
Elanco Animal Health Inc
 1,872,157 $46,073,783

All Filings in COLL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,513,504 621,920
2026-03-31 $23,265,670 703,528
2025-12-31 $25,176,689 543,773
2025-09-30 $1,179,617 33,713
2024-09-30 $10,692,885 276,731
2024-06-30 $2,342,131 72,737
2024-03-31 $10,811,874 278,513
2023-12-31 $6,751,531 219,348
2023-09-30 $9,622,636 430,543
2023-06-30 $7,998,663 372,204
2023-03-31 $7,505,847 312,874